Global Anti-erectile Dysfunction (ED) Drugs Market Growth 2026-2032
The global Anti-erectile Dysfunction (ED) Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-erectile Dysfunction (ED) Drugs Industry Forecast? looks at past sales and reviews total world Anti-erectile Dysfunction (ED) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-erectile Dysfunction (ED) Drugs sales for 2026 through 2032. With Anti-erectile Dysfunction (ED) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-erectile Dysfunction (ED) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-erectile Dysfunction (ED) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-erectile Dysfunction (ED) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-erectile Dysfunction (ED) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-erectile Dysfunction (ED) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-erectile Dysfunction (ED) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-erectile Dysfunction (ED) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-erectile Dysfunction (ED) Drugs Industry Forecast? looks at past sales and reviews total world Anti-erectile Dysfunction (ED) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-erectile Dysfunction (ED) Drugs sales for 2026 through 2032. With Anti-erectile Dysfunction (ED) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-erectile Dysfunction (ED) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-erectile Dysfunction (ED) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-erectile Dysfunction (ED) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-erectile Dysfunction (ED) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-erectile Dysfunction (ED) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-erectile Dysfunction (ED) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-erectile Dysfunction (ED) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sildenafil (Viagra)
- Vardenafil (Levitra, Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- Hospital
- Retail Pharmacy
- Clinic
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vivus, Inc.
- Lilly ICOS LLC
- Pfizer
- Bayer
- Hims
- Menarini Group
- Lupin
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- General Factory
- CSBio
- Dong-A ST
- Metuchen Pharma
- Seoul Pharma
- Teva Pharma
- S.K. Chemicals
- What is the 10-year outlook for the global Anti-erectile Dysfunction (ED) Drugs market?
- What factors are driving Anti-erectile Dysfunction (ED) Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Anti-erectile Dysfunction (ED) Drugs market opportunities vary by end market size?
- How does Anti-erectile Dysfunction (ED) Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-erectile Dysfunction (ED) Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-erectile Dysfunction (ED) Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-erectile Dysfunction (ED) Drugs Segment by Type
2.2.1 Sildenafil (Viagra)
2.2.2 Vardenafil (Levitra, Staxyn)
2.2.3 Tadalafil (Cialis)
2.2.4 Avanafil (Stendra)
2.2.5 Udenafil (Zydena)
2.2.6 Others
2.2.7 Anti-erectile Dysfunction (ED) Drugs Sales by Type
2.2.7.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
2.2.7.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Type (2021-2026)
2.3 Anti-erectile Dysfunction (ED) Drugs Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Clinic
2.3.4 Online Pharmacy
2.3.5 Anti-erectile Dysfunction (ED) Drugs Sales by Application
2.3.5.1 Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-erectile Dysfunction (ED) Drugs Breakdown Data by Company
3.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Company
3.4 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Product Location Distribution
3.4.2 Players Anti-erectile Dysfunction (ED) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-ERECTILE DYSFUNCTION (ED) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-erectile Dysfunction (ED) Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-erectile Dysfunction (ED) Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.4 APAC Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.5 Europe Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.6 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country
5.1.1 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
5.3 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region
6.1.1 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
6.3 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-erectile Dysfunction (ED) Drugs by Country
7.1.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
7.3 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs by Country
8.1.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs
10.3 Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
10.4 Industry Chain Structure of Anti-erectile Dysfunction (ED) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-erectile Dysfunction (ED) Drugs Distributors
11.3 Anti-erectile Dysfunction (ED) Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-ERECTILE DYSFUNCTION (ED) DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size Forecast by Region
12.1.1 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Type (2027-2032)
12.7 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Vivus, Inc.
13.1.1 Vivus, Inc. Company Information
13.1.2 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Vivus, Inc. Main Business Overview
13.1.5 Vivus, Inc. Latest Developments
13.2 Lilly ICOS LLC
13.2.1 Lilly ICOS LLC Company Information
13.2.2 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Lilly ICOS LLC Main Business Overview
13.2.5 Lilly ICOS LLC Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Hims
13.5.1 Hims Company Information
13.5.2 Hims Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hims Main Business Overview
13.5.5 Hims Latest Developments
13.6 Menarini Group
13.6.1 Menarini Group Company Information
13.6.2 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Menarini Group Main Business Overview
13.6.5 Menarini Group Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
13.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
13.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business Overview
13.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
13.9 General Factory
13.9.1 General Factory Company Information
13.9.2 General Factory Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 General Factory Main Business Overview
13.9.5 General Factory Latest Developments
13.10 CSBio
13.10.1 CSBio Company Information
13.10.2 CSBio Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CSBio Main Business Overview
13.10.5 CSBio Latest Developments
13.11 Dong-A ST
13.11.1 Dong-A ST Company Information
13.11.2 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Dong-A ST Main Business Overview
13.11.5 Dong-A ST Latest Developments
13.12 Metuchen Pharma
13.12.1 Metuchen Pharma Company Information
13.12.2 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Metuchen Pharma Main Business Overview
13.12.5 Metuchen Pharma Latest Developments
13.13 Seoul Pharma
13.13.1 Seoul Pharma Company Information
13.13.2 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Seoul Pharma Main Business Overview
13.13.5 Seoul Pharma Latest Developments
13.14 Teva Pharma
13.14.1 Teva Pharma Company Information
13.14.2 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Teva Pharma Main Business Overview
13.14.5 Teva Pharma Latest Developments
13.15 S.K. Chemicals
13.15.1 S.K. Chemicals Company Information
13.15.2 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 S.K. Chemicals Main Business Overview
13.15.5 S.K. Chemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-erectile Dysfunction (ED) Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-erectile Dysfunction (ED) Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-erectile Dysfunction (ED) Drugs Segment by Type
2.2.1 Sildenafil (Viagra)
2.2.2 Vardenafil (Levitra, Staxyn)
2.2.3 Tadalafil (Cialis)
2.2.4 Avanafil (Stendra)
2.2.5 Udenafil (Zydena)
2.2.6 Others
2.2.7 Anti-erectile Dysfunction (ED) Drugs Sales by Type
2.2.7.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
2.2.7.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Type (2021-2026)
2.3 Anti-erectile Dysfunction (ED) Drugs Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Clinic
2.3.4 Online Pharmacy
2.3.5 Anti-erectile Dysfunction (ED) Drugs Sales by Application
2.3.5.1 Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-erectile Dysfunction (ED) Drugs Breakdown Data by Company
3.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Company
3.4 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Product Location Distribution
3.4.2 Players Anti-erectile Dysfunction (ED) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-ERECTILE DYSFUNCTION (ED) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-erectile Dysfunction (ED) Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-erectile Dysfunction (ED) Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.4 APAC Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.5 Europe Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.6 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country
5.1.1 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
5.3 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region
6.1.1 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
6.3 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-erectile Dysfunction (ED) Drugs by Country
7.1.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
7.3 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs by Country
8.1.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs
10.3 Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
10.4 Industry Chain Structure of Anti-erectile Dysfunction (ED) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-erectile Dysfunction (ED) Drugs Distributors
11.3 Anti-erectile Dysfunction (ED) Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-ERECTILE DYSFUNCTION (ED) DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size Forecast by Region
12.1.1 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Type (2027-2032)
12.7 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Vivus, Inc.
13.1.1 Vivus, Inc. Company Information
13.1.2 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Vivus, Inc. Main Business Overview
13.1.5 Vivus, Inc. Latest Developments
13.2 Lilly ICOS LLC
13.2.1 Lilly ICOS LLC Company Information
13.2.2 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Lilly ICOS LLC Main Business Overview
13.2.5 Lilly ICOS LLC Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Hims
13.5.1 Hims Company Information
13.5.2 Hims Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hims Main Business Overview
13.5.5 Hims Latest Developments
13.6 Menarini Group
13.6.1 Menarini Group Company Information
13.6.2 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Menarini Group Main Business Overview
13.6.5 Menarini Group Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
13.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
13.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business Overview
13.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
13.9 General Factory
13.9.1 General Factory Company Information
13.9.2 General Factory Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 General Factory Main Business Overview
13.9.5 General Factory Latest Developments
13.10 CSBio
13.10.1 CSBio Company Information
13.10.2 CSBio Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CSBio Main Business Overview
13.10.5 CSBio Latest Developments
13.11 Dong-A ST
13.11.1 Dong-A ST Company Information
13.11.2 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Dong-A ST Main Business Overview
13.11.5 Dong-A ST Latest Developments
13.12 Metuchen Pharma
13.12.1 Metuchen Pharma Company Information
13.12.2 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Metuchen Pharma Main Business Overview
13.12.5 Metuchen Pharma Latest Developments
13.13 Seoul Pharma
13.13.1 Seoul Pharma Company Information
13.13.2 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Seoul Pharma Main Business Overview
13.13.5 Seoul Pharma Latest Developments
13.14 Teva Pharma
13.14.1 Teva Pharma Company Information
13.14.2 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Teva Pharma Main Business Overview
13.14.5 Teva Pharma Latest Developments
13.15 S.K. Chemicals
13.15.1 S.K. Chemicals Company Information
13.15.2 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 S.K. Chemicals Main Business Overview
13.15.5 S.K. Chemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-erectile Dysfunction (ED) Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-erectile Dysfunction (ED) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sildenafil (Viagra)
Table 4. Major Players of Vardenafil (Levitra, Staxyn)
Table 5. Major Players of Tadalafil (Cialis)
Table 6. Major Players of Avanafil (Stendra)
Table 7. Major Players of Udenafil (Zydena)
Table 8. Major Players of Others
Table 9. Global Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 10. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Table 11. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2021-2026) & ($ million)
Table 12. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2021-2026)
Table 13. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Anti-erectile Dysfunction (ED) Drugs Sale by Application (2021-2026) & (K Units)
Table 15. Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2021-2026)
Table 16. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2021-2026) & ($ million)
Table 17. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2021-2026)
Table 18. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Anti-erectile Dysfunction (ED) Drugs Sales by Company (2021-2026) & (K Units)
Table 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company (2021-2026)
Table 21. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2021-2026)
Table 23. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Producing Area Distribution and Sales Area
Table 25. Players Anti-erectile Dysfunction (ED) Drugs Products Offered
Table 26. Anti-erectile Dysfunction (ED) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Anti-erectile Dysfunction (ED) Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Geographic Region (2021-2026)
Table 31. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Anti-erectile Dysfunction (ED) Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2021-2026)
Table 35. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026) & (K Units)
Table 38. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2021-2026)
Table 39. Americas Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 41. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 42. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region (2021-2026) & (K Units)
Table 43. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2021-2026)
Table 44. APAC Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 46. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Anti-erectile Dysfunction (ED) Drugs
Table 56. Key Market Challenges & Risks of Anti-erectile Dysfunction (ED) Drugs
Table 57. Key Industry Trends of Anti-erectile Dysfunction (ED) Drugs
Table 58. Anti-erectile Dysfunction (ED) Drugs Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Anti-erectile Dysfunction (ED) Drugs Distributors List
Table 61. Anti-erectile Dysfunction (ED) Drugs Customer List
Table 62. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Vivus, Inc. Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 77. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 78. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Vivus, Inc. Main Business
Table 80. Vivus, Inc. Latest Developments
Table 81. Lilly ICOS LLC Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 83. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Lilly ICOS LLC Main Business
Table 85. Lilly ICOS LLC Latest Developments
Table 86. Pfizer Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 88. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Bayer Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Bayer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 93. Bayer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Bayer Main Business
Table 95. Bayer Latest Developments
Table 96. Hims Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Hims Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 98. Hims Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Hims Main Business
Table 100. Hims Latest Developments
Table 101. Menarini Group Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 103. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Menarini Group Main Business
Table 105. Menarini Group Latest Developments
Table 106. Lupin Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Lupin Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 108. Lupin Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Lupin Main Business
Table 110. Lupin Latest Developments
Table 111. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 113. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business
Table 115. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
Table 116. General Factory Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. General Factory Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 118. General Factory Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. General Factory Main Business
Table 120. General Factory Latest Developments
Table 121. CSBio Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. CSBio Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 123. CSBio Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. CSBio Main Business
Table 125. CSBio Latest Developments
Table 126. Dong-A ST Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 128. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Dong-A ST Main Business
Table 130. Dong-A ST Latest Developments
Table 131. Metuchen Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 133. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Metuchen Pharma Main Business
Table 135. Metuchen Pharma Latest Developments
Table 136. Seoul Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 138. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Seoul Pharma Main Business
Table 140. Seoul Pharma Latest Developments
Table 141. Teva Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 143. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Teva Pharma Main Business
Table 145. Teva Pharma Latest Developments
Table 146. S.K. Chemicals Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 148. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. S.K. Chemicals Main Business
Table 150. S.K. Chemicals Latest Developments
Table 1. Anti-erectile Dysfunction (ED) Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-erectile Dysfunction (ED) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sildenafil (Viagra)
Table 4. Major Players of Vardenafil (Levitra, Staxyn)
Table 5. Major Players of Tadalafil (Cialis)
Table 6. Major Players of Avanafil (Stendra)
Table 7. Major Players of Udenafil (Zydena)
Table 8. Major Players of Others
Table 9. Global Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 10. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Table 11. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2021-2026) & ($ million)
Table 12. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2021-2026)
Table 13. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Anti-erectile Dysfunction (ED) Drugs Sale by Application (2021-2026) & (K Units)
Table 15. Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2021-2026)
Table 16. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2021-2026) & ($ million)
Table 17. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2021-2026)
Table 18. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Anti-erectile Dysfunction (ED) Drugs Sales by Company (2021-2026) & (K Units)
Table 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company (2021-2026)
Table 21. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2021-2026)
Table 23. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Producing Area Distribution and Sales Area
Table 25. Players Anti-erectile Dysfunction (ED) Drugs Products Offered
Table 26. Anti-erectile Dysfunction (ED) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Anti-erectile Dysfunction (ED) Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Geographic Region (2021-2026)
Table 31. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Anti-erectile Dysfunction (ED) Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2021-2026)
Table 35. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026) & (K Units)
Table 38. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2021-2026)
Table 39. Americas Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 41. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 42. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region (2021-2026) & (K Units)
Table 43. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2021-2026)
Table 44. APAC Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 46. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Anti-erectile Dysfunction (ED) Drugs
Table 56. Key Market Challenges & Risks of Anti-erectile Dysfunction (ED) Drugs
Table 57. Key Industry Trends of Anti-erectile Dysfunction (ED) Drugs
Table 58. Anti-erectile Dysfunction (ED) Drugs Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Anti-erectile Dysfunction (ED) Drugs Distributors List
Table 61. Anti-erectile Dysfunction (ED) Drugs Customer List
Table 62. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Vivus, Inc. Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 77. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 78. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Vivus, Inc. Main Business
Table 80. Vivus, Inc. Latest Developments
Table 81. Lilly ICOS LLC Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 83. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Lilly ICOS LLC Main Business
Table 85. Lilly ICOS LLC Latest Developments
Table 86. Pfizer Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 88. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Bayer Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Bayer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 93. Bayer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Bayer Main Business
Table 95. Bayer Latest Developments
Table 96. Hims Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Hims Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 98. Hims Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Hims Main Business
Table 100. Hims Latest Developments
Table 101. Menarini Group Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 103. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Menarini Group Main Business
Table 105. Menarini Group Latest Developments
Table 106. Lupin Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Lupin Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 108. Lupin Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Lupin Main Business
Table 110. Lupin Latest Developments
Table 111. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 113. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business
Table 115. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
Table 116. General Factory Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. General Factory Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 118. General Factory Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. General Factory Main Business
Table 120. General Factory Latest Developments
Table 121. CSBio Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. CSBio Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 123. CSBio Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. CSBio Main Business
Table 125. CSBio Latest Developments
Table 126. Dong-A ST Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 128. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Dong-A ST Main Business
Table 130. Dong-A ST Latest Developments
Table 131. Metuchen Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 133. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Metuchen Pharma Main Business
Table 135. Metuchen Pharma Latest Developments
Table 136. Seoul Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 138. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Seoul Pharma Main Business
Table 140. Seoul Pharma Latest Developments
Table 141. Teva Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 143. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Teva Pharma Main Business
Table 145. Teva Pharma Latest Developments
Table 146. S.K. Chemicals Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 148. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. S.K. Chemicals Main Business
Table 150. S.K. Chemicals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-erectile Dysfunction (ED) Drugs
Figure 2. Anti-erectile Dysfunction (ED) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-erectile Dysfunction (ED) Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-erectile Dysfunction (ED) Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-erectile Dysfunction (ED) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sildenafil (Viagra)
Figure 12. Product Picture of Vardenafil (Levitra, Staxyn)
Figure 13. Product Picture of Tadalafil (Cialis)
Figure 14. Product Picture of Avanafil (Stendra)
Figure 15. Product Picture of Udenafil (Zydena)
Figure 16. Product Picture of Others
Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type in 2026
Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2021-2026)
Figure 19. Anti-erectile Dysfunction (ED) Drugs Consumed in Hospital
Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Market: Hospital (2021-2026) & (K Units)
Figure 21. Anti-erectile Dysfunction (ED) Drugs Consumed in Retail Pharmacy
Figure 22. Global Anti-erectile Dysfunction (ED) Drugs Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 23. Anti-erectile Dysfunction (ED) Drugs Consumed in Clinic
Figure 24. Global Anti-erectile Dysfunction (ED) Drugs Market: Clinic (2021-2026) & (K Units)
Figure 25. Anti-erectile Dysfunction (ED) Drugs Consumed in Online Pharmacy
Figure 26. Global Anti-erectile Dysfunction (ED) Drugs Market: Online Pharmacy (2021-2026) & (K Units)
Figure 27. Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2025)
Figure 28. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application in 2026
Figure 29. Anti-erectile Dysfunction (ED) Drugs Sales by Company in 2026 (K Units)
Figure 30. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company in 2026
Figure 31. Anti-erectile Dysfunction (ED) Drugs Revenue by Company in 2026 ($ millions)
Figure 32. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company in 2026
Figure 33. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Geographic Region in 2026
Figure 35. Americas Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 36. Americas Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 37. APAC Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 38. APAC Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 39. Europe Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 40. Europe Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 43. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2026
Figure 44. Americas Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2021-2026)
Figure 45. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 46. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 47. United States Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region in 2026
Figure 52. APAC Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2021-2026)
Figure 53. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 54. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 55. China Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. India Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2026
Figure 63. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2021-2026)
Figure 64. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 65. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 66. Germany Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. France Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 74. Egypt Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs in 2026
Figure 80. Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
Figure 81. Industry Chain Structure of Anti-erectile Dysfunction (ED) Drugs
Figure 82. Channels of Distribution
Figure 83. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Forecast by Region (2027-2032)
Figure 84. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Anti-erectile Dysfunction (ED) Drugs
Figure 2. Anti-erectile Dysfunction (ED) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-erectile Dysfunction (ED) Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-erectile Dysfunction (ED) Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-erectile Dysfunction (ED) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sildenafil (Viagra)
Figure 12. Product Picture of Vardenafil (Levitra, Staxyn)
Figure 13. Product Picture of Tadalafil (Cialis)
Figure 14. Product Picture of Avanafil (Stendra)
Figure 15. Product Picture of Udenafil (Zydena)
Figure 16. Product Picture of Others
Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type in 2026
Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2021-2026)
Figure 19. Anti-erectile Dysfunction (ED) Drugs Consumed in Hospital
Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Market: Hospital (2021-2026) & (K Units)
Figure 21. Anti-erectile Dysfunction (ED) Drugs Consumed in Retail Pharmacy
Figure 22. Global Anti-erectile Dysfunction (ED) Drugs Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 23. Anti-erectile Dysfunction (ED) Drugs Consumed in Clinic
Figure 24. Global Anti-erectile Dysfunction (ED) Drugs Market: Clinic (2021-2026) & (K Units)
Figure 25. Anti-erectile Dysfunction (ED) Drugs Consumed in Online Pharmacy
Figure 26. Global Anti-erectile Dysfunction (ED) Drugs Market: Online Pharmacy (2021-2026) & (K Units)
Figure 27. Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2025)
Figure 28. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application in 2026
Figure 29. Anti-erectile Dysfunction (ED) Drugs Sales by Company in 2026 (K Units)
Figure 30. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company in 2026
Figure 31. Anti-erectile Dysfunction (ED) Drugs Revenue by Company in 2026 ($ millions)
Figure 32. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company in 2026
Figure 33. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Geographic Region in 2026
Figure 35. Americas Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 36. Americas Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 37. APAC Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 38. APAC Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 39. Europe Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 40. Europe Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue 2021-2026 ($ millions)
Figure 43. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2026
Figure 44. Americas Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2021-2026)
Figure 45. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 46. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 47. United States Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region in 2026
Figure 52. APAC Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2021-2026)
Figure 53. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 54. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 55. China Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. India Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2026
Figure 63. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2021-2026)
Figure 64. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 65. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 66. Germany Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. France Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2021-2026)
Figure 74. Egypt Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs in 2026
Figure 80. Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
Figure 81. Industry Chain Structure of Anti-erectile Dysfunction (ED) Drugs
Figure 82. Channels of Distribution
Figure 83. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Forecast by Region (2027-2032)
Figure 84. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Application (2027-2032)
